⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26852980 | 1.00 | — | — | |
| SCHEMBL26852981 | 1.00 | — | — | |
| SCHEMBL22198846 | 0.93 | EPHX2 (0.35) | — | |
| SCHEMBL19734420 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL22415178 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL24480776 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL19318045 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL19318047 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL6292947 | 0.90 | EPHX2 (0.37) | — | |
| SCHEMBL19318044 | 0.90 | EPHX2 (0.37) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4400988-A2 | SYSTEM AND METHOD FOR URL FETCHING RETRY MECHANISM | BRIGHT DATA LTD. (IL) | 2024-07-17 | — | — | EP | disclosed |
| EP-4311204-A2 | METHOD FOR IMPROVING CONTENT FETCHING BY SELECTING TUNNEL DEVICES | BRIGHT DATA LTD. (IL) | 2024-01-24 | — | — | EP | disclosed |
| EP-3770773-B1 | METHOD FOR IMPROVING CONTENT FETCHING BY SELECTING TUNNEL DEVICES | BRIGHT DATA LTD (IL) | 2024-01-24 | — | — | EP | disclosed |
| EP-4199479-A1 | IMPROVING CONTENT FETCHING BY SELECTING TUNNEL DEVICES GROUPED ACCORDING TO GEOGRAPHIC LOCATION | BRIGHT DATA LTD. (IL) | 2023-06-21 | — | — | EP | disclosed |
| EP-4187881-A1 | IMPROVING CONTENT FETCHING BY SELECTING TUNNEL DEVICES GROUPED ACCORDING TO GEOGRAPHIC LOCATION | BRIGHT DATA LTD. (IL) | 2023-05-31 | — | — | EP | disclosed |
| EP-4184896-A1 | CONTENT FETCHING THROUGH INTERMEDIATE DEVICE | BRIGHT DATA LTD. (IL) | 2023-05-24 | — | — | EP | disclosed |
| WO-2022035792-A1 | POLYMER ELECTROLYTE COMPOSITES | ECOLECTRO, INC. (US) | 2022-02-17 | — | — | WO | disclosed |
| US-20210305605-A1 | HYDROGEN-ENERGY CONTROL SYSTEM AND CONTROL METHOD FOR HYDROGEN-ENERGY CONTROL SYSTEM | Toshiba Energy Systems & Solutions Corporation (JP) | 2021-09-30 | — | — | US | disclosed |
| WO-2021161887-A1 | COMPOUND | 住友化学株式会社 | 2021-08-19 | — | — | WO | disclosed |
| US-10633584-B2 | Method for making a perovskite quantum dot material | SHENZHEN TCL NEW TECHNOLOGY CO., LTD (CN) | 2020-04-28 | — | — | US | disclosed |
| CN-104370909-B | Tricyclic compound | ABBVIE 公司 | 2018-09-11 | — | — | CN | disclosed |
| US-7687507-B2 | Pyrrolo[2,3-d]pyrimidine compounds | PFIZER INC. (US) | 2010-03-30 | — | — | US | disclosed |
| US-20050171128-A1 | Pyrrolo[2,3-d]pyrimidine compounds | PFIZER INC | 2005-08-04 | — | — | US | disclosed |
| US-6890929-B2 | Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease | PFIZER, INC. (US) | 2005-05-10 | — | — | US | disclosed |
| EP-1087970-B1 | PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS | PFIZER PROD INC (US) | 2004-04-28 | — | — | EP | disclosed |
| US-20030212273-A1 | Pyrrolo [2,3-D] pyrimidine compounds | PFIZER INC. | 2003-11-13 | — | — | US | disclosed |
| US-6610847-B2 | Tyrosine kinase inhibitors; immunosuppressants | PFIZER INC. | 2003-08-26 | — | — | US | disclosed |
| US-20020019526-A1 | Pyrrolo[2,3-d]pyrimidine compounds | PFIZER INC. | 2002-02-14 | — | — | US | disclosed |
| EP-1087970-A1 | PYRROLO 2,3-d]PYRIMIDINE COMPOUNDS | Pfizer Products Inc. (US) | 2001-04-04 | — | — | EP | disclosed |
| WO-1999065908-A1 | PYRROLO[2,3-d]PYRIMIDINE COMPOUNDS | PFIZER PRODUCTS INC. (US) | 1999-12-23 | — | — | WO | disclosed |